GENT Gentian Diagnostics ASA
38.60NOK0.00%Mkt Cap: 55.78M $P/E: —1d ago
Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. It offers in-vitro diagnostic reagents for clinical chemi…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap55.78M USD
Enterprise Value49.36M USD
Revenue (TTM)17.02M USD
Gross Profit9.18M USD
Net Income (TTM)1.24M USD
Revenue/Share11.80 NOK
Last Price38.60 NOK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees63
CountryNO
SectorHealthcare
IndustryMedical Devices
ISINNO0010748866
Valuation
P/E (Trailing)—
P/E (Forward)14.81
PEG—
EV/EBITDA20.39
EV/Revenue2.90
P/S3.24
P/B3.23
EPS (TTM)-0.55
EPS (Forward)2.58
52W Range
33.5019% of range60.00
52W High60.00 NOK
52W Low33.50 NOK
Profitability
Gross Margin55.64%
Oper. Margin11.88%
EBITDA Margin14.22%
Profit Margin7.51%
ROE6.47%
ROA5.13%
Growth
Revenue Growth14.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.98M USD
CapEx (TTM)1.01M USD
FCF Margin0.79%
FCF Yield0.24%
Net Debt-5.85M USD
Net Debt/EBITDA-2.41
Balance Sheet
Debt/Equity0.11
Current Ratio7.43
Quick Ratio5.20
Book Value/Sh11.82 NOK
Cash/Share5.13 NOK
Dividends
Fwd Div Rate0.60 NOK
Trail. Div Rate0.60 NOK
Div. Yield1.57%
5Y Avg Yield—
Payout Ratio46.51%
Ex-Div DateMay 6, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)60.00 NOK
Upside (mean)+55.4%
Target Range60.00 NOK – 60.00 NOK
# Analysts1
Ownership
Shares Out.15.46M
Float7.28M
Insiders44.26%
Institutions32.12%
Technical
SMA 5039.01 (-1.1%)
SMA 20042.30 (-8.7%)
Beta0.52
S&P 52W Chg16.45%
Avg Vol (30d)3.67K
Avg Vol (10d)2.15K
Technical Indicators
RSI (14)50.6
MACD-0.1549
MACD Signal-0.1911
MACD Hist.+0.0362
BB Upper40.02 NOK
BB Middle38.50 NOK
BB Lower36.98 NOK
BB Width7.88%
ATR (14)1.135 NOK
Vol Ratio (20d)2.93x